Concepedia

Author

B. Kannan

United States Food and Drug Administration

Also Known As

B Kannan, B. Kannan, Bhanu Kannan

16

Publications

391

Citations

8

H-Index

31

Concepts

All Affiliations

United States Food and Drug Administration
BK

About

B. Kannan is an author at United States Food and Drug Administration specializing in cell biology, cell signaling, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

305

2

Cell Biology

5

5

305

3

Cellular Physiology

3

3

268

4

Natural Sciences

2

2

49

5

Biochemistry

1

1

37

B. Kannan

×

8

Publications

386

Citations

8

H-Index

YearCitations

Amphiregulin induces tyrosine phosphorylation of the epidermal growth factor receptor and p185erbB2. Evidence that amphiregulin acts exclusively through the epidermal growth factor receptor at the surface of human epithelial cells.

G R Johnson, B. Kannan, M. Shoyab,

Journal of Biological Chemistry

1993

140

Characterization of a growth factor that binds exclusively to the erbB-2 receptor and induces cellular responses.

Ruth Lupu, Rámón Colomer, B. Kannan,

Proceedings of the National Academy of Sciences

1992

116

[8] Generation of monoclonal antibodies against phosphotyrosine and their use for affinity purification of phosphotyrosine-containing proteins

A. Raymond Frackelton, Marshall R. Posner, B. Kannan,

Methods in enzymology on CD-ROM/Methods in enzymology

1991

37

Frequent Immunohistochemical Detection of EGF Supergene Family Members in Ovarian Carcinogenesis

Kurt Stromberg, Gibbes R. Johnson, Dennis M. O’Connor,

International Journal of Gynecological Pathology

1994

33

mRNA phenotyping of the major ligands and receptors of the EGF supergene family in human ovarian epithelial cells

Alfred W. Gordon, J. Pegues, Gibbes R. Johnson,

Cancer Letters

1995

26

Changes in tyrosine-phosphorylated p190 and its association with p120 type I and p100 type II rasGAPs during myelomonocytic differentiation of human leukemic cells.

Jack C. Y. Cheng, A. Raymond Frackelton, Elaine L. Bearer,

PubMed

1995

12

ErbB receptor expression and growth response to heregulin beta 1 in five ovarian carcinoma lines.

J. Pegues, B. Kannan, Kurt Stromberg

International Journal of Oncology

1999

11

Altered expression of GLS2 indicates a poor prognosis and correlates with clinicopathological features of oral squamous cell carcinoma

B. Kannan, Chu Pandi, Anitha Pandi,

International Journal of Oral and Maxillofacial Surgery

2024

11

Page 1